NDC 0409-2634-25 - Hydromorphone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-2634
- Requested NDC
- 0409-2634-25
- Package NDCs from labels
- 0409-2634-10, 0409-2634-01, 0409-2634-25, 0409-2634-05, 0409-2634-50
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydromorphone Hydrochloride - Hospira, Inc. | Hospira, Inc. | 2026-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-2634-01 | Hydromorphone Hydrochloride | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 25 | |
| 0409-2634-05 | Hydromorphone Hydrochloride | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 25 | |
| 0409-2634-10 | Hydromorphone Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 1 | 25 | |
| 0409-2634-25 | Hydromorphone Hydrochloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 25 | |
| 0409-2634-50 | Hydromorphone Hydrochloride | 1 in 1 BOX | INJECTION, SOLUTION | 1 | 25 | |
| 0409-2634-50 | Hydromorphone Hydrochloride | 50 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 50 | 25 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-2634-01 | ML - Milliliter | 0409-2634 | b7377bdd-1824-4f21-a656-504cb1608fd4 | 1 | 2012-07-24 |
| 0409-2634-05 | ML - Milliliter | 0409-2634 | b7231e2f-35ef-4ce1-91c4-545811e5fdad | 1 | 2012-07-24 |
| 0409-2634-10 | ML - Milliliter | 0409-2634 | cdcd3427-6adc-4e47-b157-bd6a12714ba6 | 1 | 2020-07-13 |
| 0409-2634-25 | ML - Milliliter | 0409-2634 | 9c74d04e-e0ae-49c9-a5a0-30f5166c6c37 | 1 | 2020-07-13 |
| 0409-2634-50 | ML - Milliliter | 0409-2634 | a2ab3c41-c4e3-4d1c-9466-66e4ba8567ed | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | ACTIVE INGREDIENT | L960UP2KRW | HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| HYDROMORPHONE | ACTIVE MOIETY | Q812464R06 | HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | HYDROMORPHONE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Redpharm Drug | 59d88866-e1ba-9d97-e063-6394a90a7b27 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 67e79859-4efc-4ea7-8211-cadf746bc864 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| IDkit HP ONE | CITRIC ACID ANHYDROUS AND 13C UREA | Meridian Bioscience Israel Ltd | 8baab7a7-5d20-46ad-9c4a-762992ef6b51 | 2026-07-28 | Warnings, Adverse reactions | 2968PHW8QP |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 31d5a37a-0e90-4e88-be14-75c877be9de2 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Dilaudid | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 9eebd88a-5632-460f-b7b6-26c8a180540d | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e034eb96-03e0-46e1-8b92-5e1f94555e7b | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 1724341 1724338 1724340 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | SpecGx LLC | 4c5c1cc8-c42b-46e3-ad68-8e22f57101f2 | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | 2427814c-f32b-8ac5-99b8-5e886fd2d001 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | 2968PHW8QP |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | 1Q73Q2JULR |
| GUNA-CELL | ACETYLCARNITINE, L-AMPC-ALPHA-LIPOIC AC-A-TOCOPHEROL-ASCORBIC ACID-CALC CARB-CITRIC AC-COBALAMIN-COLCHICUM-CONIUM-CUPRIC SULF-HERRING SPERM DNA-FERROUS FUMARATE-FOLIC ACID-FUMARIC ACID-KALI ASPARTATE-MANG PHOS-MANG GLUCONATE-MANG PHOS II-PYRUVALDEHYDE-NAT OXALACETICUM-SODIUM PYRUVATE-NIACIN-PANTOTHENIC ACID-PH-PODOPHYLLUM PELTATUM-PYRIDOXINE HYDROCHLORIDE-RIBOFLAVIN-SACCHAROMYCES CEREVISIAE RNA-SELENOMETHIONINE-SUCCINIC ACID-SULFUR-THIAMINE HYDROCHLORIDE-ZINC | Guna spa | 90db80ed-c037-4e8f-a7f6-304a65f9fe22 | 2026-06-11 | Warnings | 2968PHW8QP |
| GUNA-FLAM | ACONITUM NAPELLUS - APIS MELLIFERA - ATROPA BELLADONNA - BASIC CUPRIC CARBONATE - BRYONIA ALBA ROOT - CALCIUM SULFIDE - CITRIC ACID MONOHYDRATE - FERRIC PHOSPHATE - INTERLEUKIN-10 - MELATONIN - METENKEFALIN - PHYTOLACCA AMERICANA ROOT - RANCID BEEF - SODIUM PYRUVATE - SUS SCROFA CONJUNCTIVA - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - TRANSFORMING GROWTH FACTOR BETA-1 - ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT - | Guna spa | 7bda7eb0-8fd5-42d9-b336-39920bfc964d | 2026-06-10 | Warnings | 2968PHW8QP |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 53ddcacc-99e4-8b21-e063-6394a90a3e79 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Dilaudid | HYDROMORPHONE HYDROCHLORIDE | Rhodes Pharmaceuticals LLC | d6b40e39-a57e-402c-b4f6-7041e832f837 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Teva Parenteral Medicines, Inc. | f0b78db9-a38c-41bb-8233-5e93f7f18c5c | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | ANDA078591 1724341 1724338 1724340 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Rhodes Pharmaceuticals LLC | 37565441-0d95-4743-a695-d7b3326f58a1 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.